News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘BreastCancer’ clear

  • Using a novel three-part screening process, scientists at Dana-Farber Cancer Institute have identified a gene that is made inappropriately in about a third of all breast cancers. The discovery, reached in collaboration with researchers at Brigham and Womens Hospital (BWH) and the Broad Institute of Harvard and MIT, is reported in the June 15, 2007, issue of the journal Cell.

Tags: BasicResearch, BreastCancer

  • In a new study, women with relatively small, HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted therapy following surgery or radiation therapy were very unlikely to have the cancer recur within a few years of treatment.

Tags: chemotherapy, BreastCancer, TargetedTherapy

  • Dana-Farber has opened a mammography suite within the Whittier Street Health Center, located in Boston's Roxbury neighborhood.

Tags: BreastCancer, Disparities, Imaging

  • Erica Mayer, MD, MPH, is a breast cancer expert at Dana-Farber. She says there are at least five simple ways women can reduce their risk of getting the disease.

Tags: BreastCancer, Genetics, Prevention

  • Breast cancer risk and prevention experts comment on new guidelines suggesting women ages 40 to 49 do not need regular breast cancer screenings.

Tags: BreastCancer

  • Kornelia Polyak, MD, PhD, and colleagues identified a network of growth-spurring genes that drive stem-like breast cancer cells enriched in triple-negative breast tumors.

Tags: BreastCancer, Genomics

  • Younger women are more likely to be diagnosed with later-stage breast cancer, and treatment may affect fertility. Dana-Farber's specialized program addresses the unique needs of these patients.

Tags: BreastCancer

  • Susan G. Komen for the Cure, the world's largest grassroots network of breast cancer survivors and activists, has announced the appointment of Eric P. Winer, MD, a nationally known medical oncologist, researcher and educator from the Dana-Farber Cancer Institute and Harvard Medical Center, as its chief scientific advisor.

Tags: BreastCancer

  • Dana-Farber's Judy Garber, MD, MPH, an internationally recognized leader in clinical and translational research on breast cancer, has been elected to the Institute of Medicine.

Tags: BreastCancer, Honors, Genetics

  • Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.

Tags: BasicResearch, BreastCancer, Genomics, OvarianCancer, GynecologicCancers

Showing 11-20 of 42 items